Evaluation of Neutrophil to Lymphocyte Ratio in Patients With Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma Treated With a Combination of Cetuximab and Nivolumab in a Phase II Clinical Trial
在II期临床试验中,对接受西妥昔单抗和纳武利尤单抗联合治疗的复发和/或转移性头颈部鳞状细胞癌患者的中性粒细胞与淋巴细胞比值进行评估
期刊:American Journal of Clinical Oncology-Cancer Clinical Trials
影响因子:1.8
doi:10.1097/COC.0000000000001255
Park, Robin; Rind, Fahad; Kristoff, Tyler; Li, Jiannong; Schell, Michael; Slebos, Robbert J C; Thatikonda, Sowjanya; Chaudhary, Ritu; Biernacki, Maria I; Meshkovska, Yeva; Kaldas, David; Kim, Hyun-Su; Farinhas, Joaquim; Hernandez-Prera, Juan; Kirtane, Kedar; Hall, MacLean S; Amelio, Antonio L; Rocco, James W; Bhateja, Priyanka; Steuer, Conor; Bonomi, Marcelo; Saba, Nabil F; Chung, Christine H